---
figid: PMC4160009__RevDiabeticStud-10-228-001
figtitle: Metformin and Cancer
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
pmcid: PMC4160009
filename: RevDiabeticStud-10-228-001.jpg
figlink: /pmc/articles/PMC4160009/figure/F1/
number: F1
caption: Metformin activates adenosine-monophosphate-activated protein kinase (AMPK),
  which phosphorylates the target of rapamycin complex 2 (TORC2), thereby blocking
  its nuclear translocation and transcription of the genes involved in gluconeogenesis.
  Liver kinase B1 (LKB1) is essential for the activation of AMPK. Positive AMPK signals
  prevent the mitogenic activity of mammalian target of rapamycin (mTOR) C1 pathway.
papertitle: Metformin and Cancer.
reftext: Natalia G. Vallianou, et al. Rev Diabet Stud. 2013 Winter;10(4):228-235.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8772407
figid_alias: PMC4160009__F1
figtype: Figure
redirect_from: /figures/PMC4160009__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4160009__RevDiabeticStud-10-228-001.html
  '@type': Dataset
  description: Metformin activates adenosine-monophosphate-activated protein kinase
    (AMPK), which phosphorylates the target of rapamycin complex 2 (TORC2), thereby
    blocking its nuclear translocation and transcription of the genes involved in
    gluconeogenesis. Liver kinase B1 (LKB1) is essential for the activation of AMPK.
    Positive AMPK signals prevent the mitogenic activity of mammalian target of rapamycin
    (mTOR) C1 pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - STK11
  - CRTC2
  - Metformin
---
